1H NMR spectroscopy analysis of metabolites in the kidneys provides new insight into pathophysiological mechanisms: Applications for treatment with Cordyceps sinensis

Nephrology Dialysis Transplantation

Volumn 27, Issue 2, 2012, Pages 556-565

  Zhong, Fang ^a   Liu, Xia ^b   Zhou, Qiao ^a   Hao, Xu ^a   Lu, Ying ^a   Guo, Shanmai ^a   Wang, Weiming ^a   Lin, Donghai ^b,c   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c XIAMEN UNIVERSITY   (China)

Author keywords

5 6 nephrectomy; 1H NMR spectroscopy analysis; Cordyceps sinensis; metabonomics; pathophysiology

Indexed keywords

ADENOSINE; ALLANTOIN; ASPARTIC ACID; BETAINE; CARNITINE; CHOLINE; CREATININE; FORMIC ACID; FUMARIC ACID; GLUTAMIC ACID; GLYCINE; HERBACEOUS AGENT; INOSITOL; ISOLEUCINE; LACTIC ACID; LEUCINE; MALIC ACID; METHIONINE; NICOTINAMIDE; PHOSPHOYLCHOLINE; PROLINE; SUCCINIC ACID; TAURINE; UNCLASSIFIED DRUG; VALINE; BRANCHED CHAIN AMINO ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENERGY METABOLISM; MALE; METABOLITE; MOLECULAR DYNAMICS; NEPHRECTOMY; NONHUMAN; OPHIOCORDYCEPS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RENAL PROTECTION; ALBUMINURIA; ANIMAL; BLOOD; CHINESE MEDICINE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CORDYCEPS; DISEASE MODEL; METABOLISM; METABOLOMICS; METHODOLOGY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RANDOMIZATION; REFERENCE VALUE; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ALBUMINURIA; AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; BLOOD UREA NITROGEN; CORDYCEPS; CREATININE; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS; MULTIVARIATE ANALYSIS; NEPHRECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 84863183008     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr368     Document Type: Article

References (55)

1. Hallan SI, Orth SR. The conundrum of chronic kidney disease classification and end-stage renal risk prediction in the elderly-what is the right approach? Nephron Clin Pract 2010; 116: c307-c316
2. Wei LB, Huang LW. Strategies and methods of integrated traditional Chinese and Western medicine in preventing and treating chronic kidney disease. Zhong Xi Yi Jie He Xue Bao 2008; 6: 449-453
3. Paterson RR. Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 2008; 69: 1469-1495
4. Chen J, Zhang W, Lu T et al. Morphological and genetic characterization of a cultivated Cordyceps sinensis fungus and its polysaccharide component possessing antioxidant property in H22 tumor-bearing mice. Life Sci 2006; 78: 2742-2748
5. Weng SC, Chou CJ, Lin LC et al. Immunomodulatory functions of extracts from the Chinese medicinal fungus Cordyceps cicadae. J Ethnopharmacol 2002; 83: 79-85
6. Zhou X, Gong Z, Su Y et al. Cordyceps fungi: natural products, pharmacological functions and developmental products. J Pharm Pharmacol 2009; 61: 279-291
7. Ngai HH, Sit WH, Wan JM. The nephroprotective effects of the herbal medicine preparation, WH301, on the chemical-induced acute and chronic renal failure in rats. Am J Chin Med 2005; 33: 491-500
8. Wang Y, Yin HP, Lv XB et al. Protection of chronic renal failure by a polysaccharide from Cordyceps sinensis. Fitoterapia 2010; 81: 397-402
9. Wojcikowski K, Johnson DW, Gobe G. Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. J Lab Clin Med 2006; 147: 160-166
10. Xu F, Huang JB, Jiang L et al. Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kidney-transplanted recipients. Nephrol Dial Transplant 1995; 10: 142-143
11. Zhao X, Li L. [Cordyceps sinensis in protection of the kidney from cyclosporine A nephrotoxicity]. Zhonghua Yi Xue Za Zhi 1993; 73: 410-412, . 447
12. Wang Y, Wang M, Ling Y et al. Structural determination and antioxidant activity of a polysaccharide from the fruiting bodies of cultured Cordyceps sinensis. Am J Chin Med 2009; 37: 977-989
13. Gavaghan CL, Holmes E, Lenz E et al. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett 2000; 484: 169-174
14. Lin HM, Barnett MP, Roy NC et al. Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease. J Proteome Res 2010; 9: 1965-1975
15. Makinen VP, Soininen P, Forsblom C et al. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 2008; 4: 167
16. Murdoch TB, Fu H, MacFarlane S et al. Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice. Anal Chem 2008; 80: 5524-5531
17. Bollard ME, Contel NR, Ebbels TM et al. NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat. J Proteome Res 2010; 9: 59-69
18. Tripathi P, Bala L, Saxena R et al. 1H NMR spectroscopic study of blood serum for the assessment of liver function in liver transplant patients. J Gastrointestin Liver Dis 2009; 18: 329-336
19. Slupsky CM, Rankin KN, Fu H et al. Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. J Proteome Res 2009; 8: 5550-5558
20. Beger RD, Sun J, Schnackenberg LK. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol 2010; 243: 154-166
21. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res 2007; 6: 469-479
22. Lan MJ, McLoughlin GA, Griffin JL et al. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 2009; 14: 269-279
23. Bjerrum JT, Nielsen OH, Hao F et al. Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. J Proteome Res 2010; 9: 954-962
24. Zhao X, Zhang Y, Meng X et al. Effect of a traditional Chinese medicine preparation Xindi soft capsule on rat model of acute blood stasis: a urinary metabonomics study based on liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 873: 151-158
25. Gu Y, Zhang Y, Shi X et al. Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta 2010; 81: 766-772
26. Peng SL, Liu XW, Zhang ZR. Investigation of therapeutic mechanism of Weiweifang on experimental gastric ulcer in rats viewing from metabonomics. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 30: 1073-1077
27. Lian F, Zhao B, Lu XM. Effect of er'zhi tiangui granule on metabonomics and level of Ca21 in follicle fluid in patients after in vitro fertilization and embryo transfer. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 30: 22-25
28. Liang X, Chen X, Liang Q et al. Metabonomic study of Chinese medicine Shuanglong Formula as an effective treatment for myocardial infarction in rats. J Proteome Res 2011; 2: 790-799
29. Wu LL, Cox A, Roe CJ et al. Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int 1997; 51: 1553-1567
30. Beckonert O, Keun HC, Ebbels TM et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2007; 2: 2692-2703
31. Weljie AM, Dowlatabadi R, Miller BJ et al. An inflammatory arthritisassociated metabolite biomarker pattern revealed by 1H NMR spectroscopy. J Proteome Res 2007; 6: 3456-3464
32. Asiago VM, Alvarado LZ, Shanaiah N et al. Early detection of recurrent breast cancer using metabolite profiling. Cancer Res 2010; 70: 8309-8318
33. Mao H, Wang H, Wang B et al. Systemic metabolic changes of traumatic critically ill patients revealed by an NMR-based metabonomic approach. J Proteome Res 2009; 8: 5423-5430
34. Cloarec O, Dumas ME, Trygg J et al. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal Chem 2005; 77: 517-526
35. Cloarec O, Dumas ME, Craig A et al. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic H-1 NMR data sets. Anal Chem 2005; 77: 1282-1289
36. Zhang S, Nagana Gowda GA, Asiago V et al. Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. Anal Biochem 2008; 383: 76-84
37. Carrola J, Rocha CM, Barros AS et al. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res 2011; 10: 221-230
38. Hwang GS, Yang JY, Ryu DH et al. Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by H-1-NMR-based metabonomics. Am J Physiol Renal Physiol 2010; 298: F461-F470
39. Lindgren F, Hansen B, KarcherWet al.Model validation by permutation tests: applications to variable selection. J Chemometr 1996; 10: 521-532
40. Westerhuis JA, Hoefsloot HCJ, Smit S et al. Assessment of PLSDA cross validation. Metabolomics 2008; 4: 81-89
41. Floege J, Alpers CE, Burns MW et al. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992; 66: 485-497
42. Kren S, Hostetter TH. The course of the remnant kidney model in mice. Kidney Int 1999; 56: 333-337
43. Santos LS, Chin EW, Ioshii SO et al. Surgical reduction of the renal mass in rats: morphologic and functional analysis on the remnant kidney. Acta Cir Bras 2006; 21: 252-257
44. Pollard PJ, Wortham NC, Tomlinson IP. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase. Ann Med 2003; 35: 632-639
45. Baysal BE. On the association of succinate dehydrogenase mutations with hereditary paraganglioma. Trends Endocrinol Metab 2003; 14: 453-459
46. Bremer J. Carnitine-metabolism and functions. Physiol Rev 1983; 63: 1420-1480
47. Bohmer T, Bergrem H, Eiklid K. Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1978; 1: 126-128
48. Junankar PR, Kirk K. Organic osmolyte channels: a comparative view. Cell Physiol Biochem 2000; 10: 355-360
49. Zablocki K, Miller SP, Garcia-Perez A et al. Accumulation of glycerophosphocholine (GPC) by renal cells: osmotic regulation of GPC:choline phosphodiesterase. Proc Natl Acad Sci USA 1991; 88: 7820-7824
50. van Gelder NM. Brain taurine content as a function of cerebral metabolic rate: osmotic regulation of glucose derived water production. Neurochem Res 1989; 14: 495-497
51. FlogelU,Niendorf T, SerkowaNet al. Changes in organic solutes, volume, energy state, and metabolism associated with osmotic stress in a glial cell line: a multinuclear NMR study. Neurochem Res 1995; 20: 793-802
52. Zhai G, Wang-Sattler R, Hart DJ et al. Serum branched-chain amino acid to histidine ratio: a novel metabolomic biomarker of knee osteoarthritis. Ann Rheum Dis 2010; 69: 1227-1231
53. Griffin JL, Blenkiron C, Valonen PK et al. High-resolution magic angle spinning H-1 NMR spectroscopy and reverse transcription-PCR analysis of apoptosis in a rat glioma. Anal Chem 2006; 78: 1546-1552
54. Al-Saffar NMS, Titley JC, Robertson D et al. Apoptosis is associated with triacyglycerol accumulation in Jurkat T-cells. Br J Cancer 2002; 86: 963-970
55. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7-10